Trial ID or NCT#
NCT01100138
Status
Purpose
Dosing of medications is based on the plasma level achieved with a given dose and how long the medicine remains in the body. This study is called pharmacokinetics-that is, what the body does to the medication. Ketamine is an intravenous medication used for anesthesia and sedation in children. However the pharmacokinetics of Ketamine has not been systematically studied. We propose to study the pharmacokinetics of ketamine in different age groups of children ranging from infants to teenagers.
Official Title
Pharmacokinetics of Ketamine in Infants and Children
Eligibility Criteria
Ages Eligible for Study: Younger than 17 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Chandra Ramamoorthy
Anesthesiologist
Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric) at the Stanford University Medical Center
Gregory Hammer
Contact us to find out if this trial is right for you.
CONTACT
Archana Verma
(650) 721-1713
View on ClinicalTrials.gov